297 related articles for article (PubMed ID: 7732169)
1. Systemic sclerosis (scleroderma). Clinical management of its major complications.
Legerton CW; Smith EA; Silver RM
Rheum Dis Clin North Am; 1995 Feb; 21(1):203-16. PubMed ID: 7732169
[TBL] [Abstract][Full Text] [Related]
2. Raynaud's phenomenon and scleroderma.
Harper FE; LeRoy EC
Compr Ther; 1981 Feb; 7(2):45-51. PubMed ID: 6163587
[No Abstract] [Full Text] [Related]
3. Current options for the treatment of systemic scleroderma.
McGee BA; Barnett MD; Small RE
Clin Pharm; 1991 Jan; 10(1):14-25. PubMed ID: 1999084
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma and related disorders: therapeutic aspects.
Denton CP; Black CM
Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):17-35. PubMed ID: 10882212
[TBL] [Abstract][Full Text] [Related]
5. Clinical aspects of localized and systemic sclerosis.
Clements P
Curr Opin Rheumatol; 1992 Dec; 4(6):843-50. PubMed ID: 1457279
[TBL] [Abstract][Full Text] [Related]
6. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
[TBL] [Abstract][Full Text] [Related]
7. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
Henness S; Wigley FM
Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
[TBL] [Abstract][Full Text] [Related]
8. Scleroderma--clinical and pathological advances.
Denton CP; Black CM
Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):271-90. PubMed ID: 15158741
[TBL] [Abstract][Full Text] [Related]
9. [Systemic scleroderma in children].
Plantin P; Gavanou J; Le Fur JM; Guillet G
Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide therapy for scleroderma.
Akesson A
Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
[TBL] [Abstract][Full Text] [Related]
12. [Lung impairment in systemic sclerosis].
Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
[TBL] [Abstract][Full Text] [Related]
13. ["Pulmonary hypertension" of the gastrointestinal tract in patients with systemic sclerosis: thoughts on a not (yet) existing disease entity].
Müller-Ladner U
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S203-5. PubMed ID: 18814097
[TBL] [Abstract][Full Text] [Related]
14. Raynaud's phenomenon and systemic sclerosis.
Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
[TBL] [Abstract][Full Text] [Related]
15. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
Steen VD; Medsger TA
Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
[TBL] [Abstract][Full Text] [Related]
16. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma in children.
Cassidy JT; Sullivan DB; Dabich L; Petty RE
Arthritis Rheum; 1977 Mar; 20(2 Suppl):351-4. PubMed ID: 263912
[TBL] [Abstract][Full Text] [Related]
18. Treatment of mixed connective tissue disease.
Kim P; Grossman JM
Rheum Dis Clin North Am; 2005 Aug; 31(3):549-65, viii. PubMed ID: 16084325
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive therapies in systemic sclerosis.
Riemekasten G; Sunderkötter C
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii49-51. PubMed ID: 16987836
[TBL] [Abstract][Full Text] [Related]
20. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
